Survival advantage of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced gastric cancer: experience from a Western tertiary referral center

BACKGROUND: Selection criteria and prognostic factors for patients with advanced gastric cancer (AGC) undergoing cytoreductive surgery (CRS) plus hyperthermic intra-operative peritoneal chemotherapy (HIPEC) have not been well defined and the literature data are not homogeneous. The aim of this study...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Langenbecks Arch Surg
Asıl Yazarlar: Rosa, Fausto, Galiandro, Federica, Ricci, Riccardo, Di Miceli, Dario, Longo, Fabio, Quero, Giuseppe, Tortorelli, Antonio Pio, Alfieri, Sergio
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Berlin Heidelberg 2021
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8208915/
https://ncbi.nlm.nih.gov/pubmed/33611693
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00423-021-02137-5
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller